On Air Now

Upcoming Shows

Program Schedule »

Listen

Listen Live Now » 1330 AM Sheboygan, WI

Weather

Current Conditions(Sheboygan,WI 53081)

More Weather »
55° Feels Like: 55°
Wind: NW 3 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Partly Cloudy 58°

Tomorrow

PM Thunderstorms 74°

Wed Night

Scattered Thunderstorms 57°

Alerts

UCI harden anti-corticoid stance

International Cycling Union (UCI) president Pat McQuaid poses before an interview with Reuters in Aigle December 13, 2012. REUTERS/Denis Bal
International Cycling Union (UCI) president Pat McQuaid poses before an interview with Reuters in Aigle December 13, 2012. REUTERS/Denis Bal

PARIS (Reuters) - The International Cycling Union (UCI) has toughened up its anti-doping policy by imposing an eight-day rest on riders following an injection of corticoids, it said on Monday.

"The UCI must be informed by the doctor applying such an injection. The No Needle Policy, introduced by the UCI to its Medical Regulations in 2011, originally stipulated that a rider must not compete for 48 hours after a local injection of glucocorticosteroids," the UCI said in a statement.

UCI president Pat McQuaid explained that a rider in need of a corticoid injection should be resting, not competing.

"A rider who raced at the weekend could receive an injection of glucocorticosteroids and be racing again in a mid-week competition," the Irishman said.

"Glucocorticosteroids are used to treat inflammations, so a rider requiring this treatment should not be racing within eight days. He or she should be attending his/her condition and resting."

Member teams of the MPCC (Mouvement Pour un Cyclisme Crédible, aka Movement for Credible Cycling) have already been abiding by this rule.

Ten World Tour (elite) teams have joined the MPCC, with four of them (Astana, Blanco, Vacansoleil, Lampre) on a probationary period.

Tour de France champion Bradley Wiggins's Team Sky, the top team in 2012, have not joined the MPCC, which was created in 2007.

(Reporting by Julien Pretot; Editing by Alison Wildey)

Comments